213136-14-2

Basic information

• Product Name: 2,4(1H,3H)-PYRIMIDINEDIONE, 1(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-(TRIMETHYLSTANNYL)-
• Synonyms: 5-TRIMETHYLSTANNYL-1-(2-DEOXY-2-FLUORO-E-D-ARABINOFURANOSYL)URACIL;2,4(1H,3H)-PYRIMIDINEDIONE, 1(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-(TRIMETHYLSTANNYL)-;FTAU;5-Trimethylstannyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil;5-Trimethylstannyl-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)uracil;1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-(trimethylstannyl)-2,4(1H,3H)-pyrimidinedione
• CAS NO: 213136-14-2
• Molecular Formula: C12H19FN2O5Sn
• Molecular Weight: 409
• Mol File: 213136-14-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,4(1H,3H)-PYRIMIDINEDIONE, 1(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-(TRIMETHYLSTANNYL)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4(1H,3H)-PYRIMIDINEDIONE, 1(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-(TRIMETHYLSTANNYL)-(213136-14-2)
• EPA Substance Registry System: 2,4(1H,3H)-PYRIMIDINEDIONE, 1(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-(TRIMETHYLSTANNYL)-(213136-14-2)

Safety Data

• Hazardous Substances Data: 213136-14-2(Hazardous Substances Data)

Usage

Chemical Properties

Colourless crystalline

Upstream product

• 661-69-8 hexamethyldistannane 
• 69123-98-4 fialuridine 

Relevant articles and documents

Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases

An agent which comprises, as an active ingredient, a radiolabeled compound as represented by the following formula or a pharmaceutically acceptable salt thereof: 1wherein R1 denotes hydrogen, or a linear- or branched-chain alkyl group having 1-8 carbon atoms, R2 denotes hydrogen, hydroxyl or a halogen substituent, R3 denotes hydrogen or fluorine substituent, R4 denotes oxygen, sulfur, or a methylene substituent, and R5 denotes a radioactive halogen substituent. The agent is stable in vivo, and either stays in cells or is incorporated in DNA, thus serving for diagnosis of tissue proliferation activity or treatment of proliferative disease.